State Population First Dose (%) Second Dose (%) Pfizer (2022-01-26) Sinovac (2022-01-26) Astrazeneca (2022-01-26) Cansino (2022-01-26)
Johor 3,781,000 0 0 3,082,884 (1st)

3,051,749 (2nd)
7,357,849 (1st)

341,454 (2nd)
332,216 (1st)

1,228,437 (2nd)
114
Kedah 2,185,100 0 0 1,596,425 (1st)

1,576,613 (2nd)
3,723,154 (1st)

209,011 (2nd)
202,839 (1st)

559,740 (2nd)
92
Kelantan 1,906,700 0 0 1,201,530 (1st)

1,180,043 (2nd)
2,613,917 (1st)

181,956 (2nd)
175,885 (1st)

239,856 (2nd)
41
Melaka 932,700 0 0 724,223 (1st)

717,559 (2nd)
1,857,583 (1st)

86,543 (2nd)
83,954 (1st)

418,595 (2nd)
27
Negeri Sembilan 1,128,800 0 0 958,705 (1st)

950,779 (2nd)
2,363,955 (1st)

110,430 (2nd)
108,930 (1st)

456,419 (2nd)
65
Pahang 1,678,700 0 0 1,193,466 (1st)

1,177,980 (2nd)
2,818,439 (1st)

149,503 (2nd)
145,523 (1st)

456,429 (2nd)
71
Perak 2,510,300 0 0 1,887,184 (1st)

1,861,350 (2nd)
4,446,333 (1st)

214,250 (2nd)
206,876 (1st)

711,380 (2nd)
129
Perlis 254,900 0 0 206,651 (1st)

204,726 (2nd)
460,447 (1st)

24,455 (2nd)
24,022 (1st)

49,724 (2nd)
10
Pulau Pinang 1,773,600 0 0 1,539,284 (1st)

1,526,262 (2nd)
3,804,931 (1st)

135,976 (2nd)
132,890 (1st)

743,519 (2nd)
75
Sabah 3,908,500 0 0 2,453,875 (1st)

2,397,473 (2nd)
5,162,075 (1st)

308,325 (2nd)
295,566 (1st)

439,322 (2nd)
69
Sarawak 2,816,500 0 0 2,180,274 (1st)

2,134,455 (2nd)
5,738,680 (1st)

266,024 (2nd)
258,973 (1st)

1,424,942 (2nd)
261
Selangor 6,538,000 0 0 4,851,848 (1st)

4,786,484 (2nd)
12,462,068 (1st)

517,911 (2nd)
501,410 (1st)

2,836,389 (2nd)
292
Terengganu 1,259,300 0 0 894,379 (1st)

881,720 (2nd)
2,042,088 (1st)

130,173 (2nd)
127,138 (1st)

271,149 (2nd)
16
W.P. Kuala Lumpur 1,773,700 0 0 3,059,909 (1st)

3,030,479 (2nd)
7,481,336 (1st)

164,889 (2nd)
163,932 (1st)

1,392,657 (2nd)
164
W.P. Labuan 99,600 0 0 82,912 (1st)

79,847 (2nd)
199,051 (1st)

9,485 (2nd)
9,279 (1st)

36,294 (2nd)
1
W.P. Putrajaya 110,000 0 0 150,322 (1st)

147,338 (2nd)
360,289 (1st)

15,602 (2nd)
15,249 (1st)

62,679 (2nd)
2
Data Source: